查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1734811

2032 年塑膠管瓶市場預測：按材料類型、封蓋類型、產能、應用、最終用戶、地區進行的全球分析

Plastic Vials Market Forecasts to 2032 - Global Analysis By Material Type, Closure Type, Capacity, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球塑膠管瓶市場預計在 2025 年達到 49 億美元，到 2032 年將達到 79 億美元，預測期內的複合年成長率為 7.1%。

塑膠管瓶是小型圓柱形容器，通常由聚乙烯、聚丙烯或 PET 等聚合物製成。設計用於安全儲存、運輸和分配液體、粉末和少量固體樣品。塑膠管瓶通常用於製藥、實驗室、化妝品和診斷應用，它重量輕、抗碎，是管瓶的經濟實惠的替代品。它們通常配有螺旋蓋、卡扣蓋或滴管蓋，以確保產品安全、防止污染並提供易用性。

根據環境管理評估研究所（IEMA）的數據，自 1950 年代以來，全球已生產了約 83 億噸塑膠。

製藥和生物製藥行業的成長

對疫苗、注射藥物和診斷解決方案的需求不斷成長，加速了對可靠包裝的需求，塑膠管瓶具有耐化學性、輕鬆操作和成本效益等優點。此外，慢性病的增加和全球人口老化正在推動藥品消費量的增加，迫使製造商採用先進的塑膠管瓶解決方案來確保產品的安全性和完整性。醫療保健基礎設施的持續成長繼續推動市場向前發展。

原物料價格波動

原物料價格波動，尤其是聚丙烯和聚乙烯等聚合物的價格波動，是塑膠管瓶市場的主要限制因素。這些波動受到油價波動、供應鏈中斷和不斷變化的環境法規等因素的影響。此外，對永續包裝和回收政策的日益重視可能會影響原料的可用性和成本結構。投入成本的不可預測性對製造商維持穩定的價格和盈利構成了挑戰，從而限制了市場擴張。

新興市場醫療支出不斷成長

隨著亞太、拉丁美洲和非洲國​​家投資擴大醫療保健基礎設施和改善治療機會，包括塑膠管瓶的藥品包裝需求正在激增。此外，政府加大疫苗接種計劃力度以及本地製藥製造業的普及也進一步加速了這一趨勢。不斷成長的中產階級人口和不斷提高的醫療保健意識正在推動持續的需求，使市場參與者能夠利用這些新興機會。

管瓶更換

管瓶因其優異的阻隔性、化學惰性和既定的監管可接受性而傳統上受到青睞，特別是對於敏感的生技藥品和高價值藥品。此外，對塑膠浸出物和環境永續性的擔憂可能會推動人們轉向玻璃替代品。此外，輕質、防碎玻璃技術的進步可能會削弱塑膠管瓶的競爭優勢，迫使製造商進行創新並使其產品與眾不同。

COVID-19的影響：

新冠疫情對塑膠管瓶市場產生了重大影響，疫苗生產和分發激增，推動了前所未有的需求。對疫苗和診斷劑的安全、無菌包裝的迫切需求加速了塑膠管瓶的採用，尤其是在大規模疫苗宣傳活動中。此外，醫療保健領域的供應鏈中斷和一次性塑膠的使用增加也促進了市場的成長。然而，疫情也加劇了人們對塑膠廢棄物管理的擔憂，促使業界重新關注永續包裝解決方案。

預計預測期內聚丙烯（PP）部分將佔最大佔有率。

預計預測期內聚丙烯 (PP) 部分將佔據最大的市場佔有率。聚丙烯的優點在於其優異的耐化學性、耐用性和成本效益，使其成為藥品包裝的首選材料。此外，PP管瓶重量輕、抗碎，並可與多種藥物相容，包括酸性和鹼性製劑。隨著環保意識的增強，其可回收性使其更具吸引力。 PP 在確保產品安全性和完整性方面的多功能性和可靠性使其成為製造商和最終用戶的首選材料，並幫助其保持市場領先地位。

預計在預測期內，螺旋蓋部分將以最高的複合年成長率成長。

預計螺旋蓋部分將在預測期內實現最高的成長率。螺旋蓋因其安全封閉、易於使用和防篡改特性而受到重視，這些對於維持藥品的無菌性和安全性至關重要。此外，與自動化和大規模生產流程的兼容性有助於製造商更有效率地業務。製藥和消費品領域對易於使用、可重新密封和抗污染封蓋的需求不斷成長，推動了螺旋蓋的快速普及，為該領域的強勁成長奠定了基礎。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率。這一優勢源於該地區龐大的人口、快速的都市化以及不斷擴張的製藥和醫療保健產業。中國和印度等國家是主要貢獻者，受益於強大的製造能力、高效的生產和不斷增加的醫療保健投資。此外，包裝藥品需求的成長和當地製藥商的激增加強了亞太地區的領導地位，使其成為塑膠管瓶生產和消費的重要中心。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。這一顯著成長將受到醫療保健支出激增、先進封裝採用率提高以及政府促進本地製造業舉措的推動。此外，該地區蓬勃發展的經濟發展、不斷成長的中階人口以及對醫療保健的日益重視正在推動持續的需求。永續包裝的創新和電子商務的快速擴張將進一步推動市場成長。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球塑膠管瓶市場（依材料類型）

  • 聚對苯二甲酸乙二醇酯（PET）
  • 聚丙烯（PP）
  • 聚乙烯（PE）
    • 高密度聚苯乙烯（HDPE）
    • 低密度聚乙烯（LDPE）
  • 其他材料類型

6. 全球塑膠管瓶市場（依封蓋類型）

  • 螺旋蓋
  • 卡扣蓋
  • 鉗口蓋
  • 其他閉合類型

7. 全球塑膠管瓶市場規模

  • 體積小（小於10ml）
  • 中等容量（10ml至50ml）
  • 大容量（50ml以上）

第8章全球塑膠管瓶市場（按應用）

  • 醫藥包裝
  • 診斷劑和樣品
  • 化妝品和個人護理
  • 化學和實驗室用途
  • 其他用途

第9章全球塑膠管瓶市場（按最終用戶）

  • 製藥和生物製藥公司
  • 契約製造組織 (CMO)/合約開發與製造組織 (CDMO)
  • 診斷與研究實驗室
  • 醫院和診所
  • 化妝品和個人護理公司
  • 化學公司

第 10 章全球塑膠管瓶市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Amcor
  • Berry Global
  • Gerresheimer
  • AptarGroup
  • ALPLA Group
  • Stevanato Group
  • Schott
  • SGD Pharma
  • DWK Life Sciences
  • Origin Pharma Packaging
  • West Pharmaceutical Services
  • Bormioli Pharma
  • Pacific Vial Manufacturing
  • O.Berk Company
  • Comar
  • Alpha Packaging
  • Silgan Holdings
  • Corning
Product Code: SMRC29448

According to Stratistics MRC, the Global Plastic Vials Market is accounted for $4.9 billion in 2025 and is expected to reach $7.9 billion by 2032 growing at a CAGR of 7.1% during the forecast period. Plastic vials are small, cylindrical containers typically made from polymers like polyethylene, polypropylene, or PET. They are designed to securely store, transport, and dispense liquids, powders, or small solid samples. Commonly used in pharmaceuticals, laboratories, cosmetics, and diagnostics, plastic vials offer lightweight, shatter-resistant, and cost-effective alternatives to glass vials. They often feature screw caps, snap-on lids, or dropper tops to ensure product safety, prevent contamination, and provide ease of use.

According to data from the Institute of Environmental Management Assessment (IEMA), since the 1950s, approximately 8.3 billion metric tons of plastic have been produced globally.

Market Dynamics:

Driver:

Growing pharmaceutical and biopharmaceutical industry

Increasing demand for vaccines, injectable medications, and diagnostic solutions has accelerated the need for reliable packaging, with plastic vials offering advantages such as chemical resistance, lightweight handling, and cost-effectiveness. Furthermore, the rise in chronic diseases and the aging global population have led to higher consumption of pharmaceuticals, compelling manufacturers to adopt advanced plastic vial solutions to ensure product safety and integrity. This ongoing growth in healthcare infrastructure continues to propel the market forward.

Restraint:

Price fluctuations of raw materials

Price volatility in raw materials, particularly polymers like polypropylene and polyethylene, poses a significant restraint for the plastic vials market. These fluctuations are influenced by changes in crude oil prices, supply chain disruptions, and evolving environmental regulations. Additionally, the increasing emphasis on sustainable packaging and recycling policies can impact raw material availability and cost structures. Such unpredictability in input costs challenges manufacturers' ability to maintain stable pricing and profitability, potentially limiting market expansion.

Opportunity:

Rising healthcare expenditure in emerging markets

Countries in Asia Pacific, Latin America, and Africa invest in expanding healthcare infrastructure and improving access to medical treatments, and the demand for pharmaceutical packaging, including plastic vials, is surging. Moreover, government initiatives to enhance immunization programs and the proliferation of local pharmaceutical manufacturing further amplify this trend. The growing middle-class population and increasing awareness about healthcare drive sustained demand, enabling market players to capitalize on these emerging opportunities.

Threat:

Substitution by glass vials

Glass vials are traditionally preferred for their superior barrier properties, chemical inertness, and established regulatory acceptance, especially for sensitive biologics and high-value drugs. Additionally, concerns over plastic leachables and environmental sustainability may encourage a shift back to glass alternatives. Furthermore, advancements in lightweight and shatter-resistant glass technologies could erode the competitive advantages of plastic vials, compelling manufacturers to innovate and differentiate their product offerings.

Covid-19 Impact:

The Covid-19 pandemic had a profound impact on the plastic vials market, driving unprecedented demand due to the surge in vaccine production and distribution. The urgent need for safe, sterile packaging for vaccines and diagnostic reagents accelerated the adoption of plastic vials, especially in mass immunization campaigns. Additionally, supply chain disruptions and increased use of single-use plastics in healthcare heightened market growth. However, the pandemic also intensified concerns over plastic waste management, prompting renewed focus on sustainable packaging solutions within the industry.

The polypropylene (PP) segment is expected to be the largest during the forecast period

The polypropylene (PP) segment is expected to account for the largest market share during the forecast period. Polypropylene's dominance stems from its excellent chemical resistance, durability, and cost-effectiveness, making it a preferred material for pharmaceutical packaging. Moreover, PP vials are lightweight, shatterproof, and compatible with a wide range of drugs, including acidic and alkaline formulations. Its recyclability further enhances its appeal amid growing environmental concerns. The versatility and reliability of PP in ensuring product safety and integrity make it the material of choice for manufacturers and end-users alike, sustaining its market leadership.

The screw caps segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the screw caps segment is predicted to witness the highest growth rate. Screw caps are favored for their secure sealing, ease of use, and tamper-evident features, which are crucial for maintaining the sterility and safety of pharmaceutical products. Additionally, their compatibility with automation and mass production processes enhances operational efficiency for manufacturers. The increasing demand for user-friendly, resealable, and contamination-resistant closures in both pharmaceutical and consumer applications is driving the rapid adoption of screw caps, positioning this segment for robust expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. This dominance is attributed to the region's vast population, rapid urbanization, and expanding pharmaceutical and healthcare sectors. Countries such as China and India are major contributors, benefiting from robust manufacturing capabilities, cost-effective production, and rising healthcare investments. Furthermore, the growing demand for packaged medicines and the proliferation of local pharmaceutical manufacturers reinforce Asia Pacific's leadership, making it a pivotal hub for both production and consumption of plastic vials.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This remarkable growth is driven by surging healthcare expenditure, increasing adoption of advanced pharmaceutical packaging, and government initiatives promoting local manufacturing. Moreover, the region's dynamic economic development, burgeoning middle-class population, and heightened focus on healthcare accessibility fuel sustained demand. Innovations in sustainable packaging and the rapid expansion of e-commerce further accelerate market growth.

Key players in the market

Some of the key players in Plastic Vials Market include Amcor, Berry Global, Gerresheimer, AptarGroup, ALPLA Group, Stevanato Group, Schott, SGD Pharma, DWK Life Sciences, Origin Pharma Packaging, West Pharmaceutical Services, Bormioli Pharma, Pacific Vial Manufacturing, O.Berk Company, Comar, Alpha Packaging, Silgan Holdings and Corning.

Key Developments:

In February 2025, Berry Global is introducing a high-quality post-consumer recycled (PCR) plastic polymer for non-contact-sensitive packaging, specifically aimed at the homecare and industrial sectors. Utilising many of the same processes used to produce Berry's proprietary contact-sensitive PCR, CleanStream(R) Home and Industrial is suitable for a wide variety of applications with exacting technical specifications. The purity degree of the recycled polymer enables it to be included in greater percentages in all types of packs and in areas which demand a high degree of functional performance, for example trigger spray heads and the lid, ring and handle of paint containers.

In December 2024, Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions.

In October 2023, Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry launches with COP (Cyclic Olefin Polymer) vials a particularly satisfactory solution for the filling and storage of highly sensitive biologics. They are suitable for mRNA active ingredients at -80°C and cryogenic temperatures. Gerresheimer is expanding its RTF portfolio of glass vials in various qualities with a product made of high-quality polymer which combines the best material properties of glass and plastic.

Material Types Covered:

  • Polyethylene Terephthalate (PET)
  • Polypropylene (PP)
  • Polyethylene (PE)
  • Other Material Types

Closure Types Covered:

  • Screw Caps
  • Snap-on Caps
  • Crimp Caps
  • Other Closure Types

Capacities Covered:

  • Small Capacity (Up to 10 ml)
  • Medium Capacity (10 ml to 50 ml)
  • Large Capacity (Above 50 ml)

Applications Covered:

  • Pharmaceutical Packaging
  • Diagnostic Reagents & Samples
  • Cosmetics & Personal Care
  • Chemicals & Laboratory Use
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
  • Diagnostic Laboratories & Research Institutes
  • Hospitals & Clinics
  • Cosmetic & Personal Care Companies
  • Chemical Companies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Plastic Vials Market, By Material Type

  • 5.1 Introduction
  • 5.2 Polyethylene Terephthalate (PET)
  • 5.3 Polypropylene (PP)
  • 5.4 Polyethylene (PE)
    • 5.4.1 High-Density Polyethylene (HDPE)
    • 5.4.2 Low-Density Polyethylene (LDPE)
  • 5.5 Other Material Types

6 Global Plastic Vials Market, By Closure Type

  • 6.1 Introduction
  • 6.2 Screw Caps
  • 6.3 Snap-on Caps
  • 6.4 Crimp Caps
  • 6.5 Other Closure Types

7 Global Plastic Vials Market, By Capacity

  • 7.1 Introduction
  • 7.2 Small Capacity (Up to 10 ml)
  • 7.3 Medium Capacity (10 ml to 50 ml)
  • 7.4 Large Capacity (Above 50 ml)

8 Global Plastic Vials Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceutical Packaging
  • 8.3 Diagnostic Reagents & Samples
  • 8.4 Cosmetics & Personal Care
  • 8.5 Chemicals & Laboratory Use
  • 8.6 Other Applications

9 Global Plastic Vials Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical & Biopharmaceutical Companies
  • 9.3 Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
  • 9.4 Diagnostic Laboratories & Research Institutes
  • 9.5 Hospitals & Clinics
  • 9.6 Cosmetic & Personal Care Companies
  • 9.7 Chemical Companies

10 Global Plastic Vials Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Amcor
  • 12.2 Berry Global
  • 12.3 Gerresheimer
  • 12.4 AptarGroup
  • 12.5 ALPLA Group
  • 12.6 Stevanato Group
  • 12.7 Schott
  • 12.8 SGD Pharma
  • 12.9 DWK Life Sciences
  • 12.10 Origin Pharma Packaging
  • 12.11 West Pharmaceutical Services
  • 12.12 Bormioli Pharma
  • 12.13 Pacific Vial Manufacturing
  • 12.14 O.Berk Company
  • 12.15 Comar
  • 12.16 Alpha Packaging
  • 12.17 Silgan Holdings
  • 12.18 Corning

List of Tables

  • Table 1 Global Plastic Vials Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Plastic Vials Market Outlook, By Material Type (2024-2032) ($MN)
  • Table 3 Global Plastic Vials Market Outlook, By Polyethylene Terephthalate (PET) (2024-2032) ($MN)
  • Table 4 Global Plastic Vials Market Outlook, By Polypropylene (PP) (2024-2032) ($MN)
  • Table 5 Global Plastic Vials Market Outlook, By Polyethylene (PE) (2024-2032) ($MN)
  • Table 6 Global Plastic Vials Market Outlook, By High-Density Polyethylene (HDPE) (2024-2032) ($MN)
  • Table 7 Global Plastic Vials Market Outlook, By Low-Density Polyethylene (LDPE) (2024-2032) ($MN)
  • Table 8 Global Plastic Vials Market Outlook, By Other Materials Types (2024-2032) ($MN)
  • Table 9 Global Plastic Vials Market Outlook, By Closure Type (2024-2032) ($MN)
  • Table 10 Global Plastic Vials Market Outlook, By Screw Caps (2024-2032) ($MN)
  • Table 11 Global Plastic Vials Market Outlook, By Snap-on Caps (2024-2032) ($MN)
  • Table 12 Global Plastic Vials Market Outlook, By Crimp Caps (2024-2032) ($MN)
  • Table 13 Global Plastic Vials Market Outlook, By Other Closure Types (2024-2032) ($MN)
  • Table 14 Global Plastic Vials Market Outlook, By Capacity (2024-2032) ($MN)
  • Table 15 Global Plastic Vials Market Outlook, By Small Capacity (Up to 10 ml) (2024-2032) ($MN)
  • Table 16 Global Plastic Vials Market Outlook, By Medium Capacity (10 ml to 50 ml) (2024-2032) ($MN)
  • Table 17 Global Plastic Vials Market Outlook, By Large Capacity (Above 50 ml) (2024-2032) ($MN)
  • Table 18 Global Plastic Vials Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Plastic Vials Market Outlook, By Pharmaceutical Packaging (2024-2032) ($MN)
  • Table 20 Global Plastic Vials Market Outlook, By Diagnostic Reagents & Samples (2024-2032) ($MN)
  • Table 21 Global Plastic Vials Market Outlook, By Cosmetics & Personal Care (2024-2032) ($MN)
  • Table 22 Global Plastic Vials Market Outlook, By Chemicals & Laboratory Use (2024-2032) ($MN)
  • Table 23 Global Plastic Vials Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 24 Global Plastic Vials Market Outlook, By End User (2024-2032) ($MN)
  • Table 25 Global Plastic Vials Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 26 Global Plastic Vials Market Outlook, By Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs) (2024-2032) ($MN)
  • Table 27 Global Plastic Vials Market Outlook, By Diagnostic Laboratories & Research Institutes (2024-2032) ($MN)
  • Table 28 Global Plastic Vials Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 29 Global Plastic Vials Market Outlook, By Cosmetic & Personal Care Companies (2024-2032) ($MN)
  • Table 30 Global Plastic Vials Market Outlook, By Chemical Companies (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.